about
Genes associated with Alzheimer's disease: an overview and current statusLate-Onset Alzheimer's Disease Genes and the Potentially Implicated PathwaysClusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathwayMarkers of cholesterol transport are associated with amyloid deposition in the brain.Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNIRecent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment.Circulating biomarkers that predict incident dementia.Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer's disease.A novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolism.Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's diseaseThe role of clusterin in amyloid-β-associated neurodegeneration.Genetics of clusterin isoform expression and Alzheimer's disease risk.Developing novel blood-based biomarkers for Alzheimer's diseaseAlzheimer's disease risk genes and mechanisms of disease pathogenesisNo diagnostic value of plasma clusterin in Alzheimer's disease.Unfolded protein response-induced ERdj3 secretion links ER stress to extracellular proteostasis.Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measuresUpregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.Proapoptotic role of nuclear clusterin in brain.Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment.Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern IndiaA correlativity study of plasma APL1β28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients.Protective role of clusterin in preserving endothelial function in AL amyloidosisMicroglial malfunction: the third rail in the development of Alzheimer's disease.Alzheimer risk variant CLU and brain function during aging.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.HDL-cholesterol and apolipoproteins in relation to dementia.Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk LociPlasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of agingEffect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohortsAdvances in blood-based protein biomarkers for Alzheimer's diseaseBiomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problemsPlasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke.Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseasesMouse models of growth hormone action and aging: a proteomic perspectivePlasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.Heterogeneous multimodal biomarkers analysis for Alzheimer's disease via Bayesian networkA potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin
P2860
Q26747803-BF9A975B-B38B-498F-BF3E-C4D8584AF220Q27014964-56CCE53D-AB43-4E14-AEF3-F01B2B2B9DFBQ29870999-8A339E19-0BA9-47C3-8F3B-F42263F530B7Q30406139-B8A86FBA-137A-4C17-B97C-86F40BA0E9EFQ31110973-93EE5722-866B-4BA2-9F4C-BEFF1750621DQ33556068-E24B07AC-BDB8-4FC5-835D-45D915B5FF94Q33610745-F495F093-73A2-4046-8F96-8125523036BDQ33752058-BF59B775-AE9E-4F39-A110-4B76321484CBQ33895177-617F26FF-8336-42FB-934B-4E4F9FD3E418Q33909566-2198547E-3B51-47E1-A4CB-A540798B2C39Q33933612-0A3A043E-D9D7-452F-9169-53EA69757EEBQ33988464-1A48E72D-0E26-45C3-85F6-5C948D9F9C43Q34233544-401DA8E2-F68B-45E8-90C7-5391CFB6A6FFQ34394080-D82A6F67-7C09-4B03-A7B9-739CFAE4DFEFQ34425904-B6C4F528-C516-401F-AE99-84D59C811E4BQ34500043-65AB5DA4-D9FD-4588-8D97-4C3F0F56F2BFQ34923990-0D83FAD6-9AFF-4A64-BA27-B6007F0833BAQ35106592-A53DD306-9743-4143-866E-E7945921812BQ35191570-C41BD48F-5C4A-4373-ABDF-B5A5955E88E9Q35374719-D056AE53-1F6E-4834-94D5-1946CCB29A92Q35394390-A1D80B17-73A6-4267-AD40-256D182B6A25Q36182245-8C813495-7803-43DA-BE00-DC8CCB607907Q36197487-498904B3-3ACE-48F9-8F3A-ABDF56DDDE59Q36209423-933273D2-3F47-4288-BF1F-1E8756A70737Q36339136-D597546F-D062-4039-A137-D5376DB0B9FBQ36348184-C0DA2E95-1059-4D4E-A101-2A8A6419444AQ36368439-07C5D533-60AF-4F09-88AB-3B9557CBE280Q36381738-60CFD5A0-4BD0-40B6-B804-1FEE36FF4F9BQ36436743-4E1A1A3E-573C-4460-BEF1-A18E881E2DB7Q36625970-CA19B862-C4E2-4455-82D1-416D28DC4BECQ36934171-25FC54CE-D2A6-4A68-88A5-0B6DA45391F9Q36941597-F65D7F7D-E235-4E4F-8E37-53487C9317B2Q36997826-E18E412D-D61F-4390-AE03-ABE454184C1EQ36997922-9A23F25C-CF42-420B-831E-A7B6B19CBE1CQ37105427-6BA8F0C6-DDB4-4C99-8A6A-7DD752F1CC4BQ37105606-602695D1-21F9-41C4-BCB6-D61D2E6481B0Q37130681-BB20E069-0BCA-4302-BB4C-99815E009A85Q37131933-3C129E8C-F9FA-47E0-A1A2-D6A79A906D9AQ37191515-D227D79B-ED9A-4858-B434-846BC3EC5B79Q37427904-0431BAB4-BC92-49AC-ADE6-44AEE211958D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Plasma clusterin and the risk of Alzheimer disease.
@ast
Plasma clusterin and the risk of Alzheimer disease.
@en
Plasma clusterin and the risk of Alzheimer disease.
@nl
type
label
Plasma clusterin and the risk of Alzheimer disease.
@ast
Plasma clusterin and the risk of Alzheimer disease.
@en
Plasma clusterin and the risk of Alzheimer disease.
@nl
prefLabel
Plasma clusterin and the risk of Alzheimer disease.
@ast
Plasma clusterin and the risk of Alzheimer disease.
@en
Plasma clusterin and the risk of Alzheimer disease.
@nl
P2093
P356
P1476
Plasma clusterin and the risk of Alzheimer disease.
@en
P2093
Elisabeth M C Schrijvers
Monique M B Breteler
Peter J Koudstaal
P304
P356
10.1001/JAMA.2011.381
P407
P577
2011-04-01T00:00:00Z